Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings

MLA

Richard W. Joseph, et al. “Health-Related Quality of Life (QoL) in Patients with Advanced Melanoma Receiving Immunotherapies in Real-World Clinical Practice Settings.” Quality of Life Research, vol. 29, May 2020, pp. 2651–60. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119e9bb144a339d1f772cb604809ecf6&authtype=sso&custid=ns315887.

APA

Richard W. Joseph, Frank Xiaoqing Liu, Qing Harshaw, Todd L. Saretsky, Alan S. Pickard, Scott J. Diede, Cynthia Macahilig, Alicia C. Shillington, & Vaidehi Dave. (2020). Health-related quality of life (QoL) in patients with advanced melanoma receiving immunotherapies in real-world clinical practice settings. Quality of Life Research, 29, 2651–2660.

Chicago

Richard W. Joseph, Frank Xiaoqing Liu, Qing Harshaw, Todd L. Saretsky, Alan S. Pickard, Scott J. Diede, Cynthia Macahilig, Alicia C. Shillington, and Vaidehi Dave. 2020. “Health-Related Quality of Life (QoL) in Patients with Advanced Melanoma Receiving Immunotherapies in Real-World Clinical Practice Settings.” Quality of Life Research 29 (May): 2651–60. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....119e9bb144a339d1f772cb604809ecf6&authtype=sso&custid=ns315887.